ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
INVESTORS
[더벨] 킴리아 맞서는 큐로셀 전략 ‘생산·가격’…’치료거점’ 한계 과제
2024/06/13
더벨 – 국내 최고 자본시장(Capital Markets) 미디어 (thebell.co.kr)
Prev
[더벨] 데이터로 입증한 큐로셀의 ‘안발셀’ 국산약 설 자리 만들다
Next
[헬로디디] 혈액암 환자 꿈의 치료제, 현실화 ‘코앞’··· ‘최초 신화’ 써내려가는 큐로셀
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
ABOUT US
SCIENCE
FACILITY
INVESTORS
Media
Notice
Public Disclosures
Stock Information
Financials
ESG
ESG Management
Archive
CONTACT
Copyright 2023. Curocell Inc. All Rights Reserved.
